T1	PROC 58 72	ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	Spec_cue 99 104	puede
T3	CHEM 114 136	fármaco hipolipemiante
T4	CHEM 154 167	pitavastatina
#2	AnnotatorNotes T4	C1101838; pitavastatin; Organic Chemical · Pharmacologic Substance
T5	LIVB 171 180	pacientes
#3	AnnotatorNotes T5	C0030705; Patients; Patient or Disabled Group
T6	DISO 185 203	cáncer de próstata
#4	AnnotatorNotes T6	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T7	PROC 232 240	tratados
T8	CHEM 256 270	antiandrógenos
#5	AnnotatorNotes T8	C0002842; Androgen Antagonists; Pharmacologic Substance
T9	CHEM 311 324	pitavastatina
#6	AnnotatorNotes T9	C1101838; pitavastatin; Organic Chemical · Pharmacologic Substance
T10	LIVB 328 337	pacientes
#7	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 342 360	cáncer de próstata
#8	AnnotatorNotes T11	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T12	PROC 361 369	tratados
T13	PROC 374 393	terapia androgénica
T14	PROC 415 443	ensayo clínico multicéntrico
T15	CHEM 483 490	fármaco
#9	AnnotatorNotes T15	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T16	CHEM 514 527	pitavastatina
#10	AnnotatorNotes T16	C1101838; pitavastatin; Organic Chemical · Pharmacologic Substance
T19	LIVB 555 564	pacientes
#11	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	DISO 569 587	cancer de próstata
#12	AnnotatorNotes T20	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T23	PROC 702 744	ensayo clínico, randomizado y simple ciego
T26	CHEM 818 827	estatinas
#14	AnnotatorNotes T26	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T27	LIVB 831 840	pacientes
#15	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	DISO 845 863	cáncer de próstata
#16	AnnotatorNotes T28	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T29	PROC 881 889	tratados
T30	CHEM 894 898	ARTA
T31	CHEM 900 912	enzalutamida
#17	AnnotatorNotes T31	C3496793; enzalutamide; Organic Chemical · Pharmacologic Substance
T32	CHEM 914 925	apalutamida
#18	AnnotatorNotes T32	C4551002; Erleada; Organic Chemical · Pharmacologic Substance
T33	CHEM 927 939	darolutamida
T34	CHEM 942 953	abiraterona
#19	AnnotatorNotes T34	C0754011; abiraterone; Organic Chemical · Pharmacologic Substance
T35	LIVB 1005 1023	grupo experimental
#20	AnnotatorNotes T35	C1320290; Clinical trial group; Patient or Disabled Group
T37	DISO 1076 1086	metástasis
#21	AnnotatorNotes T37	C0027627; Neoplasm Metastasis; Neoplastic Process | C2939419; Secondary Neoplasm; Neoplastic Process
T38	LIVB 1168 1177	Pacientes
#22	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	PROC 1182 1205	diagnóstico histológico
T40	DISO 1209 1227	cáncer de próstata
#23	AnnotatorNotes T40	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T41	LIVB 1357 1366	Pacientes
#24	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	DISO 1371 1418	cáncer de próstata metastásico hormonosensibles
T43	DISO 1420 1425	CPHSm
T44	Neg_cue 1432 1434	no
T45	CHEM 1467 1486	superantiandrógenos
T46	Negated 1467 1486	superantiandrógenos
T47	Neg_cue 1487 1489	ni
T48	PROC 1490 1503	quimioterapia
#25	AnnotatorNotes T48	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T49	Negated 1490 1503	quimioterapia
T50	LIVB 1510 1519	Pacientes
#26	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	DISO 1524 1554	cáncer de próstata metastásico
#27	AnnotatorNotes T51	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
T52	PROC 1571 1581	castración
#28	AnnotatorNotes T52	C0007344; Castration; Therapeutic or Preventive Procedure
T53	DISO 1583 1588	CPRCm
#29	AnnotatorNotes T53	C4721208; Metastatic castration-resistant prostate cancer; Neoplastic Process
T54	Neg_cue 1595 1597	no
T55	CHEM 1630 1649	superantiandrógenos
T56	Negated 1630 1649	superantiandrógenos
T57	Neg_cue 1650 1652	ni
T58	PROC 1653 1666	quimioterapia
#30	AnnotatorNotes T58	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T59	Negated 1653 1666	quimioterapia
T60	DISO 1697 1715	cáncer de próstata
#31	AnnotatorNotes T60	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T61	PROC 1732 1742	castración
#32	AnnotatorNotes T61	C0007344; Castration; Therapeutic or Preventive Procedure
T62	PROC 1783 1786	PSA
#33	AnnotatorNotes T62	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T63	Duration 1802 1821	al menos una semana
T64	PROC 1910 1913	PSA
#34	AnnotatorNotes T64	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T65	PROC 1934 1957	Niveles de testosterona
#35	AnnotatorNotes T65	C0523912; Testosterone measurement; Laboratory Procedure
T66	DISO 2010 2024	lesiones óseas
#36	AnnotatorNotes T66	C0238792; Bone lesion; Disease or Syndrome
T67	PROC 2032 2048	gammagrafía ósea
#37	AnnotatorNotes T67	C0203668; Radioisotope scan of bone; Diagnostic Procedure | C3889015; Bone scintigraphy; Diagnostic Procedure
T68	DISO 2065 2092	lesiones de tejidos blandos
#38	AnnotatorNotes T68	C0410013; Soft tissue lesion; Pathologic Function
T69	LIVB 2125 2134	Pacientes
#39	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	DISO 2139 2157	cáncer de próstata
#40	AnnotatorNotes T70	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T71	PROC 2174 2184	castración
#41	AnnotatorNotes T71	C0007344; Castration; Therapeutic or Preventive Procedure
T72	Neg_cue 2185 2187	no
T73	DISO 2188 2200	metastásicos
#42	AnnotatorNotes T73	C4255448; Metastasis; Pathologic Function
T74	Negated 2188 2200	metastásicos
T75	DISO 2202 2208	CRPCnm
T76	PROC 2253 2256	PSA
#43	AnnotatorNotes T76	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T77	Duration 2257 2266	< 6 meses
T78	LIVB 2277 2286	pacientes
#44	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	DISO 2291 2294	CaP
#45	AnnotatorNotes T79	C0013274; Patent ductus arteriosus; Congenital Abnormality | C0033036; Atrial Premature Complexes; Disease or Syndrome
T80	PROC 2308 2319	tratamiento
#46	AnnotatorNotes T80	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T81	CHEM 2340 2348	fármacos
#47	AnnotatorNotes T81	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T82	DISO 2365 2375	enfermedad
#48	AnnotatorNotes T82	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T83	CHEM 2379 2390	Abiraterona
#49	AnnotatorNotes T83	C0754011; abiraterone; Organic Chemical · Pharmacologic Substance
T84	CHEM 2394 2406	Enzalutamida
#50	AnnotatorNotes T84	C3496793; enzalutamide; Organic Chemical · Pharmacologic Substance
T85	CHEM 2410 2421	Apalutamida
#51	AnnotatorNotes T85	C4551002; Erleada; Organic Chemical · Pharmacologic Substance
T86	CHEM 2425 2437	Darolutamida
T87	CHEM 2442 2449	Fármaco
#52	AnnotatorNotes T87	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T88	CHEM 2485 2498	pitavastatina
#53	AnnotatorNotes T88	C1101838; pitavastatin; Organic Chemical · Pharmacologic Substance
T89	Dose 2499 2503	2 mg
T90	LIVB 2536 2545	Pacientes
#54	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T91	DISO 2550 2564	hiperlipidemia
#55	AnnotatorNotes T91	C0020473; Hyperlipidemia; Disease or Syndrome | C0020476; Hyperlipoproteinemias; Disease or Syndrome
T92	PROC 2583 2594	diagnóstico
#56	AnnotatorNotes T92	C0011900; Diagnosis; Diagnostic Procedure
T94	PROC 2611 2636	tratamiento farmacológico
#57	AnnotatorNotes T94	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T95	Neg_cue 2611 2636	tratamiento farmacológico
T96	LIVB 2642 2651	Pacientes
#58	AnnotatorNotes T96	C0030705; Patients; Patient or Disabled Group
T97	PROC 2656 2680	niveles de transaminasas
T98	LIVB 2725 2734	Pacientes
#59	AnnotatorNotes T98	C0030705; Patients; Patient or Disabled Group
T101	LIVB 2812 2821	Pacientes
#60	AnnotatorNotes T101	C0030705; Patients; Patient or Disabled Group
T102	Neg_cue 2826 2834	rechacen
T104	Neg_cue 2862 2864	no
T105	PROC 2875 2899	consentimiento informado
#61	AnnotatorNotes T105	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T106	Negated 2875 2899	consentimiento informado
T36	Spec_cue 616 621	puede
T25	Negated 2202 2208	CRPCnm
T100	PROC 2852 2859	estudio
T103	Negated 2852 2859	estudio
T107	Speculated 114 136	fármaco hipolipemiante
T108	Speculated 154 167	pitavastatina
T22	DISO 634 661	progresión de la enfermedad
T18	Speculated 634 661	progresión de la enfermedad
T24	Neg_cue 2603 2605	no
